In Association with National Society of Regenerative Medicine

Call (561) 221-2000

×
  • Home
  • Open Studies
    • Sexual Dysfunction – Gurnee Illinois
    • Sexual Dysfunction – Denver Colorado
    • Hair Regeneration Study – San Francisco
    • Chronic Lateral Epicondylitis and/or Medial Epicondylitis Study – Jupiter, FL
    • Hair Regeneration Study – Oakbrook Terrace, IL
    • Screening Center for Atherosclerosis – Florida
    • Lumbar Spinal Stenosis Study – Boca Raton, FL
    • Knee Osteoarthritis – Danvers, MA
    • Knee Osteoarthritis – Oakbrook Terrace, IL
  • Research Centers
  • Become a Partner
  • Publications
  • Contact

Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy

July 11, 2017

Various source-derived mesenchymal stem cells (MSCs) have been considered for cell therapeutics in incurable diseases. To characterize MSCs from different sources, we compared human bone marrow (BM), adipose tissue (AT), and umbilical cord blood-derived MSCs (UCB-MSCs) for surface antigen expression, differentiation ability, proliferation capacity, clonality, tolerance for aging, and paracrine activity. Although MSCs from different tissues have similar levels of surface antigen expression, immunosuppressive activity, and differentiation ability, UCB-MSCs had the highest rate of cell proliferation and clonality, and significantly lower expression of p53, p21, and p16, well known markers of senescence. Since paracrine action is the main action of MSCs, we examined the anti-inflammatory activity of each MSC under lipopolysaccharide (LPS)-induced inflammation. Co-culture of UCB-MSCs with LPS-treated rat alveolar macrophage, reduced expression of inflammatory cytokines including interleukin-1α (IL-1α), IL-6, and IL-8 via angiopoietin-1 (Ang-1). Using recombinant Ang-1 as potential soluble paracrine factor or its small interference RNA (siRNA), we found that Ang-1 secretion was responsible for this beneficial effect in part by preventing inflammation. Our results demonstrate that
primitive UCB-MSCs have biological advantages in comparison to adult sources, making
UCB-MSCs a useful model for clinical applications of cell therapy.

MSC Compartive Analysis Hye

Add Comment Cancel


Recent Posts

  • Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
  • In vivo clinical and radiological effects of platelet-rich plasma on interstitial supraspinatus lesion: Case series
  • Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration
  • Treatment of chronic low back pain – new approaches on the horizon
  • Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease

Archives

  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • July 2017

Categories

  • Adipose Tissue
  • Alopecia
  • Amniotic Allograft
  • Atherosclerosis
  • Back Pain
  • Bone Marrow
  • COPD
  • Crohn’s Disease
  • Degenerative Joint Disease
  • Diabetes
  • ED
  • Elbow Pain
  • Facial Rejuvenation
  • Hair Restoration
  • Hearing Loss
  • Ischemic Stroke
  • Knee Osteoarthritis
  • Lateral Epicondylitis
  • Lupus
  • Medial Epicondylitis
  • Mesenchymal Stem Cells
  • Migraines
  • Multiple Sclerosis
  • Non Healing Wounds
  • Osteoarthritis
  • Platelet Rich Plasma – PRP
  • Publications
  • Rotator Cuff
  • Sexual Dysfunction
  • Skin Diseases
  • Skin Rejuvenation
  • Stem Cells
  • Tendons and Ligaments
  • Traumatic Brain Injury
  • Umbilical Cord
  • Urinary Incontinence
  • Wharton’s Jelly

(561) 221-2000

info@clinicalstudyresearch.com

141 NW 20th Street, Boca Raton, FL 33431

Copyright ©2018 All Rights Reserved.
Designed by NWOL